Jump to: Authorized Access | Attribution | Authorized Requests

Study Description

In this study, we performed paired tumor/normal long insert whole genome and exome sequencing and tumor RNA sequencing on primary or metastatic acral melanoma tumors collected from 34 patients. Patients were enrolled from either Vanderbilt University or the Memorial Sloan-Kettering Cancer Center. We report an integrated analysis of DNA and RNA sequencing data to describe genomic and transcriptomic characteristics of acral melanoma.

Authorized Access
Publicly Available Data (Public ftp)
Molecular Data
TypeSourcePlatformNumber of Oligos/SNPsSNP Batch IdComment
Whole Genome Sequencing KAPA Biosystems Kapa Hyper Library Preparation Kit N/A N/A
RNA Sequencing Illumina TruSeq RNA Library Preparation Kit V2 N/A N/A
RNA Sequencing Illumina TruSeq RNA Access Library Prep V1.0 N/A N/A
Exome Sequencing KAPA Biosystems Kapa Hyper Library Preparation Kit N/A N/A
Exome Sequencing Agilent SureSelect Human All Exon V5+UTR N/A N/A
Selected Publications
Diseases/Traits Related to Study (MeSH terms)
Links to Related Resources
Authorized Data Access Requests
Study Attribution
  • Principal Investigator
    • Jeffrey Sosman, MD. Vanderbilt University Medical Center, Nashville, TN, USA.
  • Co-Investigators
    • Jeffrey Trent, PhD. Translational Genomics Research Institute, Phoenix, AZ, USA.
    • Charlotte Ariyan, MD. Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
    • Winnie Liang, PhD. Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Funding Source
    • Acral Genomics Team Science Award. Melanoma Research Alliance (MRA), NW Washington, DC, USA.